Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warns Matrixx On Combination Supplement/Drug Products

This article was originally published in The Tan Sheet

Executive Summary

Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
Advertisement

Related Content

Cirrus Earplugs Looks To OTC Sleep Aids For Partnership
FDA Regulation Of Homeopathics Does Not Pre-empt Damages Claims – Court
Homeopathics Reap Rewards From Sowing Fields For Success – Hyland's CEO
Matrixx Bought By Private Equity Firm H.I.G., Settles Personal Injury Lawsuits
FDA Underlines Disapproval Of Drug-Supplement Combos In Letter To P&G
FDA Underlines Disapproval Of Drug-Supplement Combos In Letter To P&G
Matrixx Launches Zicam Products To Rebound During Cold Season
FDA Uses "Unusual" Action To Get Matrixx's Zicam Off The Market
Bayer Warning Letters Reinforce FDA Ban On Supplement/Drug Combinations
Pheniramine, Phenylephrine Combo Excluded From Cough/Cold Monograph

Topics

Advertisement
UsernamePublicRestriction

Register

PS105125

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel